Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Thomas Werner
Age : 65
Public asset : 17,913 USD
Linked companies : Basilea Pharmaceutica AG
Thomas Werner is a German businessperson who has been at the head of 8 different companies and currently occupies the position of Chairman at Claudio BidCo A.

He is also on the board of Basilea Pharmaceutica AG, SuppreMol GmbH and Robert Koch Stiftung eV.

In the past Dr. Werner occupied the position of Chairman-Supervisory Board of 4SC AG, President & Chief Executive Officer at Cerecin, Inc., Managing Director at Central Europe GmbH, Chairman at Fertin Pharma A, Executive Chairman for PharmaSwiss SA, Non-Executive Chairman for CM&D Pharma Ltd., Managing Director & Senior Vice President at GlaxoSmithKline GmbH & Co. KG, Managing Director at Glaxo Wellcome GmbH & Co. KG, Managing Director at Bristol-Myers Squibb GmbH & Co. KGaA, Managing Director at Convatec (Germany) GmbH and Investment Committee at Seventure Partners SA.

Dr. Werner received a doctorate from the University of Gottingen.

Current positions of Thomas Werner 
NameTitle Since
Basilea Pharmaceutica AG
(Biotechnology & Medical Research)
Vice Chairman 2018
Claudio BidCo A/S Chairman 2017
SuppreMol GmbH Director -
Robert Koch Stiftung eV Trustee 2010

Holdings of Thomas Werner 
Basilea Pharmaceutica AG (BSLN)
(Biotechnology & Medical Research)
4000.0031%17,913 USD

Thomas Werner: Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
08:14aELON MUSK : human-like robots and self-driving cars
01:41pBERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
More news

© 2022 People and Ownership :   
Thomas Werner : Connections